Management ChangeAug 6, 2026, 04:09 PM
Omada Health Names Wei-Li Shao CEO; Q2 Revenue $88M, +43%
AI Summary
Omada Health announced a leadership transition, with President Wei-Li Shao succeeding co-founder Sean Duffy as CEO, effective January 1, 2027. Mr. Duffy will transition to Executive Chair, and Jeryl Hilleman will become Lead Independent Director. Concurrently, the company reported strong second-quarter 2026 financial results, with revenue growing 43% to $88 million and achieving a net income of $5 million, a significant improvement from a net loss in the prior year. Omada Health also raised its full-year 2026 revenue and Adjusted EBITDA guidance, reflecting continued operational momentum and profitability.
Key Highlights
- Wei-Li Shao appointed CEO, effective January 1, 2027; Sean Duffy to become Executive Chair.
- Jeryl Hilleman appointed Lead Independent Director, effective January 1, 2027.
- Q2 2026 revenue reached $88 million, a 43% increase from $61 million in Q2 2025.
- Q2 2026 net income was $5 million, compared to a net loss of $5 million in Q2 2025.
- Q2 2026 Adjusted EBITDA was $11 million, up from a $0.2 million loss in Q2 2025.
- Total Members increased 45% year over year, reflecting strong demand.
- Full-year 2026 revenue guidance raised to $334M-$340M (midpoint 30% growth).
- Full-year 2026 Adjusted EBITDA guidance raised to $21M-$27M (midpoint 4x increase).
Price Impact
More from OMDA